GREEN CROSS WellBeing Corporation Logo

GREEN CROSS WellBeing Corporation

Develops personalized nutrition solutions, from prescription injections to supplements & cosmetics.

234690 | KO

Overview

Corporate Details

ISIN(s):
KR7234690006
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 여의대로 108 파크원타워2 33층, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

GREEN CROSS WellBeing Corporation is a healthcare company specializing in personalized nutrition solutions. The company develops, manufactures, and markets a diverse portfolio of products, including prescription nutritional therapy injections, where it is a market leader with products like Laennec. Its offerings also include a wide range of health supplements and functional foods, featuring customized solutions like the Dr.PNT and Dr.Pack brands tailored to individual needs. Other key areas include the development of specialized probiotics for different life stages and a cosmetics line derived from proprietary cell culture technology. The company actively engages in R&D to discover novel functional materials from natural sources and to develop new pharmaceutical treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.7 MB
2025-08-01 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.2 KB
2025-06-09 00:00
Governance Information
공정거래자율준수프로그램운영현황
Korean 5.4 KB
2025-05-29 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-04-30 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.4 KB
2025-04-09 00:00
M&A Activity
[기재정정]타법인주식및출자증권취득결정
Korean 30.8 KB
2025-04-04 00:00
M&A Activity
[기재정정]타법인주식및출자증권취득결정
Korean 31.0 KB
2025-03-25 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 25.0 KB
2025-03-25 00:00
Governance Information
공정거래자율준수프로그램운영현황
Korean 15.6 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 25.0 KB
2025-03-17 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.9 MB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 189.6 KB
2025-03-10 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 168.6 KB
2025-02-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 93.4 KB

Automate Your Workflow. Get a real-time feed of all GREEN CROSS WellBeing Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GREEN CROSS WellBeing Corporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GREEN CROSS WellBeing Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biotech firm using enzyme tech for pharma, healthcare, and bioprocess CDMO services.
South Korea
092040
AMICUS THERAPEUTICS, INC. Logo
Develops advanced therapies for rare lysosomal storage disorders.
United States of America
FOLD
AMINOLOGICS CO.,LTD. Logo
Manufactures high-purity chiral amino acids & APIs for pharma, chemical, and food industries.
South Korea
074430
Amneal Pharmaceuticals, Inc. Logo
Develops & commercializes essential medicines: generics, injectables & specialty drugs.
United States of America
AMRX
Amphastar Pharmaceuticals, Inc. Logo
Develops and manufactures complex injectable, intranasal, and inhalation pharmaceutical products.
United States of America
AMPH
Amylyx Pharmaceuticals, Inc. Logo
Developing novel therapies for neurodegenerative diseases like ALS and Wolfram syndrome.
United States of America
AMLX
AN2 Therapeutics, Inc. Logo
Developing novel small molecule drugs for infectious diseases and oncology using boron chemistry.
United States of America
ANTX
Develops approved cannabinoid medicines for pain, epilepsy, and heart failure.
United Kingdom
ANAN
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapies for autoimmune and inflammatory diseases.
United States of America
ANAB
Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.
Türkiye
ANGEN

Talk to a Data Expert

Have a question? We'll get back to you promptly.